Demonstrates selective meta-CH methylation in anilines and anisoles, indicating a new approach for drug modification.
The introduction of methyl groups into drug candidates is a widely used strategy in medicinal chemistry to improve pharmaceutical properties. However, the introduction of methyl groups to the meta ‐position of electron‐rich arenes is a key challenge, since it is complementary to the natural reactivity in electrophilic aromatic substitutions and therefore mostly relies on prefunctionalized substrates or directing groups. Herein, we disclose a selective meta ‐CH methylation of anilines and anisole derivatives that eliminates the need for less step‐economical prefunctionalization strategies, enabled by a Pd/S, O‐ligand/norbornene cooperative catalytic system with the potential for modification and isotope labeling of drug candidates and natural products.
No takes yet. Share an insight, caveat, or question.
Papp et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: